Clinical Trials · NCT05790447
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Second Affiliated Hospital of Soochow University
- Enrollment
- 60
- Start date
- Apr 2023
- Locations
- 1 site, China
- Primary endpoint
- Overall response rate (ORR)